Recital 4, Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 Decembe…

In forcecited 4×

This Regulation aims to facilitate the development and accessibility of medicinal products for use in the paediatric population, to ensure that medicinal products used to treat the paediatric population are subject to ethical research of high quality and are appropriately authorised for use in the paediatric population, and to improve the information available on the use of medicinal products in the various paediatric populations. These objectives should be achieved without subjecting the paediatric population to unnecessary clinical trials and without delaying the authorisation of medicinal products for other age populations.

  • Judgment of the General Court (Third Chamber) of 14 December 2011. Nycomed Danmark ApS v European Medicines Agency (EMA).Decision

    In that context, recital 4 in the preamble to Regulation No 1901/2006 states that that regulation aims, first, to facilitate the development and accessibility of medicinal products for use in the paediatric population, secondly, to ensure …

    14 Dec 2011 · 62009TJ0052

  • Order of the President of the Court of First Instance of 24 April 2009. Nycomed Danmark ApS v Agence européenne des médicaments (EMEA).Decision

    24 Apr 2009 · 62009TO0052

  • Judgment of the General Court (Tenth Chamber) of 23 September 2020 (Extracts). Medac Gesellschaft für klinische Spezialpräparate mbH v EuropDecision

    In that regard, it must be emphasised that the EU legislature attaches particular importance to the availability of medicinal products for paediatric use in the European Union. To that end, it adopted Regulation (EC) No 1901/2006 of the …

    23 Sep 2020 · 62019TJ0549

  • Judgment of the Court (Second Chamber) of 21 June 2018. Pfizer Ireland Pharmaceuticals, Operations Support Group v Orifarm GmbH.Decision

    Recitals 4, 26 and 27 of Regulation No 1901/2006 are worded as follows: This Regulation aims to facilitate the development and accessibility of medicinal products for use in the paediatric population, to ensure that medicinal products used …

    21 Jun 2018 · 62016CJ0681